Next-Generation Biological Fluid Processing Systems

Publication ID: 24-11857714_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Biological Fluid Processing Systems,” Published Technical Disclosure No. 24-11857714_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857714_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,714.

Summary of the Inventive Concept

A paradigm shift in biological fluid processing, integrating machine learning, wearable technology, and real-time analytics to revolutionize fluid balance monitoring and control.

Background and Problem Solved

The original patent disclosed systems and methods for monitoring and controlling fluid balance in medical procedures, but limitations in real-time data analysis and treatment personalization hindered its potential. The new inventive concept addresses these limitations by introducing advanced technologies to provide more accurate, personalized, and efficient fluid balance management.

Detailed Description of the Inventive Concept

The next-generation biological fluid processing system comprises a machine learning module to predict optimal fluid volumes based on patient medical history and treatment data. A wearable, portable light source for extracorporeal photopheresis enables real-time monitoring and treatment. A nanofiltration module removes unwanted cellular components, and a microfluidic channel analyzes fluid composition in real-time. The system integrates with a database of genomic profiles to predict optimal treatment protocols and provide real-time feedback. In vivo monitoring of fluid balance is achieved through implantable micro-sensors, transmitting data to a remote server for analysis and feedback.

Novelty and Inventive Step

The new inventive concept's integration of machine learning, wearable technology, and real-time analytics provides a novel and non-obvious solution for biological fluid processing, surpassing the original patent's limitations and enabling more accurate, personalized, and efficient fluid balance management.

Alternative Embodiments and Variations

Alternative embodiments may include using different machine learning algorithms, varying the type of wearable technology, or incorporating additional sensors for in vivo monitoring. Variations may also include adapting the system for use in different medical procedures or integrating with other medical devices.

Potential Commercial Applications and Market

The next-generation biological fluid processing system has significant commercial potential in the medical device industry, particularly in the fields of hematology, oncology, and personalized medicine. The system's ability to provide real-time, personalized fluid balance management can improve treatment outcomes, reduce healthcare costs, and enhance patient quality of life.

CPC Classifications

SectionClassGroup
A A61 A61M1/3607
A A61 A61M1/0209
A A61 A61M1/361
A A61 A61M1/3643
A A61 A61M1/3672
A A61 A61M1/3683
A A61 A61M1/3693
A A61 A61M1/3696
A A61 A61M1/38
A A61 A61M2202/0092
A A61 A61M2202/0407
A A61 A61M2202/0413
A A61 A61M2202/0415
A A61 A61M2202/0429
A A61 A61M2202/0439
A A61 A61M2202/0443
A A61 A61M2205/3386
A A61 A61M2205/50
A A61 A61M2230/005
A A61 A61M2230/207

Original Patent Information

Patent NumberUS 11,857,714
TitleSystems and methods for monitoring and controlling fluid balance during a biological fluid procedure
Assignee(s)Fenwal, Inc.